Sandy Feng

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Management of the liver transplant patient
    Bruce Gelb
    Division of Transplantation, Department of Surgery, UCSF Medical Center, San Francisco, CA, USA
    Expert Rev Gastroenterol Hepatol 3:631-47. 2009
  2. pmc Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both?
    Sandy Feng
    University of California San Francisco, San Francisco, CA 94143 0780, USA
    Curr Opin Organ Transplant 13:506-12. 2008
  3. doi request reprint Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants
    Sandy Feng
    Division of Transplantation, Department of Surgery, University of California, San Francisco, CA 94143, USA
    JAMA 307:283-93. 2012
  4. doi request reprint Donor intervention and organ preservation: where is the science and what are the obstacles?
    S Feng
    University of California San Francisco, San Francisco, CA, USA
    Am J Transplant 10:1155-62. 2010
  5. doi request reprint Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis
    Francis Y Yao
    Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
    Hepatology 48:819-27. 2008
  6. ncbi request reprint Expanded criteria donor kidney allocation: marked decrease in cold ischemia and delayed graft function at a single center
    Jonathan T Carter
    Division of Transplant Surgery, University of California San Francisco, San Francisco, CA, USA
    Am J Transplant 5:2745-53. 2005
  7. ncbi request reprint Laparoscopic procurement of kidneys with multiple renal arteries is associated with increased ureteral complications in the recipient
    Jonathan T Carter
    Division of Transplantation Surgery, University of California San Francisco, USA
    Am J Transplant 5:1312-8. 2005
  8. ncbi request reprint Increased rejection in living unrelated versus living related kidney transplants does not affect short-term function and survival
    T Florian Fuller
    Department of Surgery, Division of Transplantation, University of California San Francisco, San Francisco, CA 94143, USA
    Transplantation 78:1030-5. 2004
  9. ncbi request reprint BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant
    Gerald S Lipshutz
    University of California, Los Angeles, Department of Surgery, Los Angeles, CA, USA
    Am J Transplant 5:366-73. 2005
  10. ncbi request reprint Comparison of outcomes after delayed graft function: sirolimus-based versus other calcineurin-inhibitor sparing induction immunosuppression regimens
    Ryan A McTaggart
    Department of Surgery, Division of Transplantation, University of California San Francisco, 94143 0780, USA
    Transplantation 78:475-80. 2004

Detail Information

Publications34

  1. doi request reprint Management of the liver transplant patient
    Bruce Gelb
    Division of Transplantation, Department of Surgery, UCSF Medical Center, San Francisco, CA, USA
    Expert Rev Gastroenterol Hepatol 3:631-47. 2009
    ..Finally, the substantial challenges of recurrent disease and long-term medical comorbidities are addressed as these are clearly the primary issues that threaten the longevity and wellbeing of the liver transplant recipient...
  2. pmc Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both?
    Sandy Feng
    University of California San Francisco, San Francisco, CA 94143 0780, USA
    Curr Opin Organ Transplant 13:506-12. 2008
    ..The aim is to review available data regarding the risks and benefits of indefinite immunosuppression against attempted immunosuppression withdrawal for children who have undergone liver transplantation...
  3. doi request reprint Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants
    Sandy Feng
    Division of Transplantation, Department of Surgery, University of California, San Francisco, CA 94143, USA
    JAMA 307:283-93. 2012
    ..Although life-saving, liver transplantation burdens children with lifelong immunosuppression and substantial potential for morbidity and mortality...
  4. doi request reprint Donor intervention and organ preservation: where is the science and what are the obstacles?
    S Feng
    University of California San Francisco, San Francisco, CA, USA
    Am J Transplant 10:1155-62. 2010
    ..Consideration will then be given to the scientific, logistical and ethical obstacles that impede the transformation of laboratory breakthroughs into innovative treatments that simultaneously improve organ quality and supply...
  5. doi request reprint Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis
    Francis Y Yao
    Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
    Hepatology 48:819-27. 2008
    ..2% and 92.1%, respectively. No patient had HCC recurrence after a median posttransplantation follow-up of 25 months. The only factor predicting treatment failure was pretreatment alpha-fetoprotein >1,000 ng/mL...
  6. ncbi request reprint Expanded criteria donor kidney allocation: marked decrease in cold ischemia and delayed graft function at a single center
    Jonathan T Carter
    Division of Transplant Surgery, University of California San Francisco, San Francisco, CA, USA
    Am J Transplant 5:2745-53. 2005
    ..0033) and cold ischemia time (OR 1.24/h; p = 0.0036). We conclude the ECD designation provides a description of kidney quality that may obviate biopsy. ECD allocation decreased cold ischemia time and DGF, which may improve graft survival...
  7. ncbi request reprint Laparoscopic procurement of kidneys with multiple renal arteries is associated with increased ureteral complications in the recipient
    Jonathan T Carter
    Division of Transplantation Surgery, University of California San Francisco, USA
    Am J Transplant 5:1312-8. 2005
    ..Given the current excellent results with right-sided donor nephrectomy, kidneys with single arteries should be preferentially procured, irrespective of side...
  8. ncbi request reprint Increased rejection in living unrelated versus living related kidney transplants does not affect short-term function and survival
    T Florian Fuller
    Department of Surgery, Division of Transplantation, University of California San Francisco, San Francisco, CA 94143, USA
    Transplantation 78:1030-5. 2004
    ..We compared outcomes of living related (LRT) versus living unrelated kidney transplants (LURT) and analyzed the effect of early rejection upon graft survival...
  9. ncbi request reprint BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant
    Gerald S Lipshutz
    University of California, Los Angeles, Department of Surgery, Los Angeles, CA, USA
    Am J Transplant 5:366-73. 2005
    ..The pancreas, however, is spared from evidence of infection, and no pancreatic rejection occurred when immunosuppression was decreased...
  10. ncbi request reprint Comparison of outcomes after delayed graft function: sirolimus-based versus other calcineurin-inhibitor sparing induction immunosuppression regimens
    Ryan A McTaggart
    Department of Surgery, Division of Transplantation, University of California San Francisco, 94143 0780, USA
    Transplantation 78:475-80. 2004
    ..This study compares transplant outcomes of SRL-based induction immunosuppression (IS) with other calcineurin-inhibitor (CNI) sparing regimens in the DGF setting...
  11. pmc Offer patterns of nationally placed livers by donation service area
    Jennifer C Lai
    Division of Gastroenterology and Hepatology, Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA
    Liver Transpl 19:404-10. 2013
    ..Here we propose changes to the national liver distribution system that will help to balance equity, efficiency, and transparency...
  12. ncbi request reprint Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy
    Shigeki Sekine
    Diabetes Center, Department of Medicine, Division of Transplantation, University of California San Francisco, San Francisco, CA 94143, USA
    Hepatology 45:361-8. 2007
    ....
  13. doi request reprint Peri-operative hyperglycemia is associated with delayed graft function in deceased donor renal transplantation
    Justin Parekh
    Division of Transplantation, Department of Surgery, University of California, San Francisco, CA 94143, USA
    Clin Transplant 27:E424-30. 2013
    ..92, 95% CI 1.20-3.05, p = 0.01). We conclude that recipient blood glucose measured in the PACU is associated with DGF and begs the question of whether improved peri-operative glucose control will decrease the incidence of DGF...
  14. ncbi request reprint Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation
    Ryan A McTaggart
    Department of Surgery, Division of Transplantation, University of California San Francisco, San Francisco, CA 94143 0780, USA
    Liver Transpl 10:975-85. 2004
    ..Alternatively, the association of HCV and EAR may result from an increased frequency of allograft biopsy and may be further exacerbated by inability to accurately diagnose EAR in the setting of recurrent HCV...
  15. ncbi request reprint Trends over a decade of pediatric liver transplantation in the United States
    Sandy Feng
    Department of Surgery, University of California San Francisco, San Francisco, CA 94143 0780, USA
    Liver Transpl 12:578-84. 2006
    ..In conclusion, the sobering reality that mortality on the waiting list remains highest for the youngest pediatric liver candidates frames our challenge for the next decade...
  16. doi request reprint Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection
    Alexander Kuo
    Division of Gastroenterology, University of California, San Diego, CA, USA
    Liver Transpl 14:1491-7. 2008
    ..004). We conclude that preemptive antiviral therapy in virologic nonresponders delays the time to subsequent HCV treatment and may confer a reduced risk of fibrosis progression. Further study of preemptive antiviral therapy is warranted...
  17. ncbi request reprint A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation
    Francis Y Yao
    Department of Medicine, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143 0538, USA
    Liver Transpl 11:1505-14. 2005
    ..3 and 81.8% at 1 and 2 yr, respectively. In conclusion, successful tumor downstaging can be achieved in the majority of carefully selected patients, but longer follow-up is needed to further access the risk of HCC recurrence after OLT...
  18. ncbi request reprint Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?
    Kayvan Roayaie
    Department of Surgery, Division of Transplantation, University of California San Francisco, San Francisco, CA 94143 0780, USA
    Liver Transpl 13:S36-43. 2007
    ....
  19. ncbi request reprint Optimizing living donor kidney graft function by donor-recipient pair selection
    Todd V Brennan
    Department of Surgery, Division of Transplantation, University of California San Francisco, San Francisco, CA 94143 0780, USA
    Transplantation 82:651-6. 2006
    ..This study was undertaken to determine the relative contributions of individual donor demographic factors on graft function following LDKT...
  20. ncbi request reprint Tumors and transplantation: The 2003 Third Annual ASTS State-of-the-Art Winter Symposium
    Sandy Feng
    Division of Transplantation, Department of Surgery, University of California San Francisco, USA
    Am J Transplant 3:1481-7. 2003
  21. ncbi request reprint Early graft function after living donor kidney transplantation predicts rejection but not outcomes
    Todd V Brennan
    Department of Surgery, Division of Transplantation, University of California San Francisco, San Francisco, CA, USA
    Am J Transplant 4:971-9. 2004
    ..We suggest that immunosuppression should be intensified in the poor EGF setting to maximize LDKT longevity, as AR does impair functional graft survival...
  22. pmc An examination of liver offers to candidates on the liver transplant wait-list
    Jennifer Cindy Lai
    Department of Medicine, Division of Gastroenterology and Hepatology, University of California San Francisco, San Francisco, California 94143, USA
    Gastroenterology 143:1261-5. 2012
    ..We aimed to characterize offers of organs to candidates awaiting liver transplantation (LT)...
  23. ncbi request reprint Magnetic resonance imaging of hepatocellular carcinoma mimicking focal nodular hyperplasia: a potential pitfall in patients with cirrhosis?
    Olga Rafaelian
    Department of Radiology, University of California San Francisco, San Francisco, CA 94143 0628, USA
    J Comput Assist Tomogr 30:796-9. 2006
    ..Recognition that hepatocellular carcinoma may mimic focal nodular hyperplasia in patients with cirrhosis may prevent misdiagnosis and allow for earlier intervention...
  24. ncbi request reprint Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation
    Chris E Freise
    Division of Transplantation, University of California San Francisco, 94143, USA
    Arch Surg 138:1121-5; discussion 1125-6. 2003
    ..Steroid avoidance is possible in simultaneous pancreas-kidney transplantation with the use of newer immunosuppressive agents and induction therapy...
  25. doi request reprint Kidney transplant performed after liver transplant: a single center experience
    Matthew H Levine
    Division of Transplant Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA
    Clin Transplant 25:915-20. 2011
    ..Death censored graft survival was statistically lower in the KALT group but this largely accrued in the first three yr after transplant and was nearly equivalent by 10 yr...
  26. ncbi request reprint Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts
    George J Chang
    Division of Transplantation Surgery, Department of Surgery, University of California, San Francisco School of Medicine, 94143, USA
    Surgery 132:149-56. 2002
    ..The purpose of this study was to modulate the immune response of rat liver transplant recipients by adenovirus-mediated gene transfer of CD40Ig, a secretable fusion protein designed to block the CD40-CD154 T-cell costimulation pathway...
  27. ncbi request reprint National conference to assess antibody-mediated rejection in solid organ transplantation
    Steven K Takemoto
    Dumont Transplant Program and Immunogenetics Center, UCLA School of Medicine, UCLA, Los Angeles, CA, USA
    Am J Transplant 4:1033-41. 2004
    ..Immunologic barriers once considered insurmountable are now consistently overcome to enable more patients to undergo organ transplantation...
  28. ncbi request reprint Selecting livers for transplantation: can beggars be choosers?
    Sandy Feng
    University of California San Francisco, San Francisco, 94143, USA
    Nat Clin Pract Gastroenterol Hepatol 2:496-7. 2005
  29. ncbi request reprint Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice
    Shigeki Sekine
    Department of Medicine, Diabetes Center, University of California San Francisco, San Francisco, CA 94143 0573, USA
    Hepatology 43:817-25. 2006
    ..In conclusion, in addition to regulating hepatocyte proliferation, beta-catenin may also control multiple aspects of normal liver function...
  30. ncbi request reprint Organ donors with malignant gliomas: an update
    Federic P Collignon
    Department of Surgery, Division of Neurosurgery, Memorial Sloane Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    Am J Transplant 4:15-21. 2004
    ..We will then present recent knowledge regarding basic glioma biology that speaks to their metastatic potential and suggest rational strategies for the post-transplant management of recipients of organs from donors with glioma...
  31. ncbi request reprint Death from donor-transmitted malignancy despite emergency liver retransplantation
    Gerald S Lipshutz
    Division of Transplantation, Department of Surgery, University of California, San Francisco, CA 94143, USA
    Liver Transpl 9:1102-7. 2003
    ..This case of donor-transmitted malignancy underscores the need for vigilance by the procuring surgeon in identifying potential malignancy during organ retrieval and use of a full autopsy on selected donors after organ procurement...
  32. ncbi request reprint Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation
    Ryan A McTaggart
    Department of Surgery, Division of Transplantation, University of California San Francisco, San Francisco, CA, USA
    Am J Transplant 3:416-23. 2003
    ..034). Sirolimus retained its profound negative association with time to graft function in all multivariate models. Because sirolimus appears to prolong DGF, it may not be the optimal immunosuppressive choice in the DGF setting...
  33. ncbi request reprint Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation
    Sandy Feng
    Department of Surgery, Division of Transplantation, University of California, San Francisco, San Francisco, CA 94143 0780, USA
    Transplantation 74:1657-63. 2002
  34. ncbi request reprint Surgical challenges in transplantation: the Fourth Annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium
    Sandy Feng
    Department of Surgery, Division of Transplantation, University of California San Francisco, USA
    Am J Transplant 5:428-35. 2005